Abstract: Coordination compounds of 5-chloroacetamido-1,3,4-thiadiazole-2-sulfonamide (Hcaz) with V(IV), Cr(lll), Fe(ll), Co(ll), Ni(ll) and Cu(ll) have been prepared and characterized by standard procedures (spectroscopic, magnetic, EPR, thermogravimetric and conductimetric measurements). Some of these compounds showed very good in vitro inhibitory properties against three physiologically relevant carbonic anhydrase (CA)isozymes, i.e., CA I, II, and IV. The differences between these isozymes in susceptibility to inhibition by these metal complexes is discussed in relationship to the characteristic features of their active sites, and is rationalized in terms useful for developing isozyme-specific CA inhibitors.
Introduction
1,3,4-Thiadiazole-2-sulfonamide derivatives za played a critical role for the development of several important classes of pharmacological agents, such as the diuretics with saluretic action, 4 benzothiadiazine and high-ceiling diuretics, 46 and the antiglaucoma drugs with carbonic anhydrase (CA) inhibitory action among others. 7 The 4Prototype of all these drugs was constituted by acetazolamide 1, the first non-mercurial diuretic, used for more than 45 years in clinical medicine as 7 10 diuretic, antiglaucoma, antiepileptic and antiulcer compound. It is still used nowadays, mainly as a diagnostic tool in NMR imaging, and in many physiological studies. 4: R = adamantyl-l-CO
The success of acetazolamide in clinical medicine fostered much research in the synthesis and pharmacological evaluation of many 1,3,4-thiadiazole-2-sulfonamide derivatives. 46 Thus, benzolamide 2 was approved in USA as a drug, and several studies showed its efficiency in emphysema, 17 but its status is nowadays that of an orphan drug, although its clinical value has never been contested. Benzolamide is also widely used in many renal and pulmonary physiological studies.
a '8 The halogeno-acetazolamides, such as chloroacetazolamide 3 led to the development of topical antiglaucoma sulfonamide CA inhibitors, TM which recently introduced in clinics, 9,o constituted one of the best treatments of open-angle glaucoma.
Metal complexes of sulfonamides of type 1-3 started to be investigated only in the last 10 years, with the report of Borras' group of the first X-ray crystallographic structure of some acetazolamide complexes. 1 It has been thereafter proved by our group that such compounds possess unexpectedly strong inhibitory properties against the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1 ), and this finding opened new vistas in the search of isozyme-specific inhibitors, as 16.26 well as other types of clinical/diagnostic applications of such enzyme inhibitors. General procedure for the preparation of complexes [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] An amount of 10 mM of sulfonamide 3 was dissolved in 50 mL of methanol-water (1:1, v/v). The stoichiometric amount of metal salt dissolved in a small amount (5 mL) of water was added (a molar ratio sulfonamide:metal salt of 1:1; 2:1 and 3:1 has been used in different experiments), and the mixture was treated with the stoichiometric amount of KOH (in order to obtain the monopotassium salt of the original sulfonamide) or with an excess of 25% acqueous amonia. The reaction mixture Ia$ been heated on a steam bath for 1-3 hours, then left overnight and the obtained precipitates were filtered and air dried. An exception from the above procedure was the preparation of complex 9, case in which trans-[Co.(en)Cl]CI has been used instead of a simple cobalt salt.
Results and Discussion
Complexes 5-17 prepared in the present study are shown in Table I , together with their elemental analysis data. .4 Synthesis in which ammonia has been used as deprotonating agent, led to the formation of metal complexes in which this molecule was present in the coordination sphere, in addition to the sulfonamide anion(s). The anion of the metal salt from which the complexes were prepared was also of much importance in the synthesis, especially for the Co(ll) and Cu(ll) derivatives, cases in which complexes with a large variety of compositions could be prepared by slight variations of the synthetic procedure described above and the metal salt employed in the preparations. In the case of the Cr(lll) derivatives, a hydrolysis of the original ligand was evidenced, with formation of 5-amino-l,3,4-thiadiazole-2-sulfonamide (Htda) which subsequently complexed (as neutral ligand) this metal ion. Such a behaviour was previously evidenced for the complexation of divalent metal ions (such as Mg(ll) and Mn(ll)) by compound 3.
Electronic spectroscopic (by the diffuse reflectance technique) data for complexes [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] are shown in Tables II IV, together with the assignements of the observed transitions. For the V(IV) complex .5 the typical transitions of V(IV) in square py.ramidal geometry were evidenced in the 37 electronic spectrum, at 26,315; 15,480 and 11,590 cm", respectively, whereas for the two Cr(lll) derivatives 16 and 17, the electronic spectral transitions are shown in Table IV , proving the presence of octahedral chromium ions in these derivatives.
The electronic spectroscopic data for the Fe(ll), Co(ll) and Ni(ll) derivatives (Table II) , although generally more complicated than for the systems mentioned above, permitted to evidence the presence of octahedral metal ions in many of the prepared complexes (such as 6, 7, 9-12), whereas for some Co(ll) derivatives (such as [8] [9] [10] , tetrahedral geometries were also found. 39'4 Proposed geometries for some of these metal ions in the prepared complexes are shown schematically below. Both complexes containing the sulfonamide-deprotonated species of sulfonamides 3 (L), as well as complexes in which the free sulfonamide itself HL or its hydrolysis product, 5-amino-l,3,4-thiadiazole-2-sulfonamide (Htda) act as ligands, have been prepared in the present study (Table I) . By comparing the IR spectra of the complexes and the corresponding ligands (Table V) , the following observations should be made" (i) the shift of the two sulfonamido vibrations (both the symmetric as well as the the assymetric one), towards lower or higher wavenumbers in the spectra of the complexes, as compared to the spectra of the corresponding ligand, as already documented previously for similar complexes.
'z This is a direct indication that the (deprotonated) sulfonamido moieties of the ligands interacts with the metal ions in the newly prepared coordination compounds; (ii) the amide vibrations (the most intense such bands at 1720 cm) of ligand 3 appear unchanged in the IR spectra of complexes 5-13, suggesting that these moieties do not participate in coordination of the metal ions. Still, this band is shifted at 1695 cm in the spectra of the two copper complexes 14 and 15, probably due to participation of this moiety in coordination of the metal ions (iii) the C=N stretching vibration in the spectra of the prepared complexes is shifted with 5-20 cm towards lower wavenumbers, as compared to the same vibration in the spectra of sulfonamides 3 and Htda, indicating that one of the endocyclic nitrogens of the thiadiazolic ring (presumably N-3) acts as donor atom, as already documented by X-ray crystallographic and spectroscopic determinations on complexes of other sulfonamides (such as 1-3) with divalent 21 27 metal ions (Table V) Thermogravimetric analysis showed the presence of coordinated water/ammonia molecules in some of the prepared complexes, which were lost in a single step, between 135-180 C, and of lattice water in the case of one complex, 17. All these compounds behaved as nonelectrolytes in DMF as solvent, except for 5 and 9 (2:1, and 1:2 electrolytes, respectively) and 17 (1:1 electrolyte) (Table V) .
By correlating all the spectroscopic, magnetic, TG and conductimetric data, one can conclude that ligand L (the conjugate base of sulfonamide 3) generally acts as a bidentate ligand in the complexes prepared here, interacting with the metal ions by means of the sulfonamido and endocyclic N-3 nitrogen atoms. An exception is the V(IV) derivative in which we consider L to act monodentately, by means of the sulfonamidic nitrogen. When HL interacts with metal ions, the donor system is probably similar to that of L, but the obtained complexes are generally much less stable (data not shown). 5-Amino-l,3,4-thiadiazole-2-sulfonamide Htda also acts as a bidentate ligand, by the same donor system as sulfonamide 3, similarly with the situation described before, when the Mg(ll); Be(ll); Zn(ll); Cd(ll), Hg(ll) and Pb(ll) complexes of this sulfonamide have been reported. The complexes ,5-17 together with the standard CA inhibitors 1-3 were assayed for inhibition against four isozymes, hCA I, hCA II, and bCA IV (Table VI) . As seen from the above data, the chloracetamido derivative 3 is more inhibitory than acetazolamide, whereas the unacylated compound Htda is less inhibitory than the above sulfonamides. The metal complexes ,5-17 are much more inhibitory than the sulfonamides from which they derive 3, and Htda, and than all other simple sulfonamides assayed. They behave similarly to the metal complexes of acetazolamide, methazolamide or dorzolamide previously reported by this group, which were all more inhibitory than the parent sulfonamide from which were prepared.
'=z Particularly strong inhibition was observed for the Co(ll); Ni(ll) and Cu(ll) complexes, especially against CA II and CA IV, the isozymes critical for aqueous humor formation.
The above differences of affinity for the different isozymes of the new inhibitors reported in this paper, and the fact that the X-ray crystallographic structure of 43 46 to be important for catalysis in isozymes I, II and IV (the files 1HUH for hCA and 2CBA for hCA II have been used, also available from Brookhaven Protein Database). 4a-4e It has previously been proposed by us 4 that the high catalytic efficiency of the most active isozyme, hCA II, is due to a unique feature of its active site: the presence of a histidine cluster, consisting of the residues: His 64 two conformations; His 4 two conformations, His 3, His 10, His 15, His 17 ( Fig. ) .44 This cluster extends from the interior of the active site (His 64) to its entrance (His 4 and His 3) till the surface of the protein (in the proximity of the active site entrance) and it probably constitutes a very appropriate "channel" for efficiently transferring protons from the active site to the reaction medium, but also for the binding of amphipatic compounds, such as the 44 47 sulfonamide inhibitors and their metal complexes.
As seen from Fig. 2 4 In this context it is also enlightening that histamine, the first activator of hCA II for which the X-ray crystal structure has recently been reported by this group, 44 which is able to enhance the catalytic efficiency of the enzyme, does really bind in the region of the active site of hCA II containing the histidine cluster shown in Fig. 1 . In this context, we suggest a new hypothesis for explaining also differences of affinity of the discussed CA isozymeS for the sulfonamide inhibitors and their metal complexes, based on the interaction of inhibitors with the structural elements of the active site mentioned above. Indeed, for example in hCA II the amino acid residue in position 4 is His, whereas in hCA lit is an Asp. This residue, situated just at the entrance within the active site, is a constituent of the histidine cluster of isozyme I1. The negative charge of the carboxylate group of the Asp residue in hCA probably influences its interaction with positive charges (such as the metal ions), present in the complex inhibitors of the type described by us here. In fact many such compounds have a higher affinity for hCA as compared to the parent, uncharged sulfonamides from which they were obtained, presumably due to a supplementary interaction between this negative charge and the cationic moiety of the inhibitor molecule.
In the case of hCA IV (Fig. 3) hCA IV and a phenylalanine in hCA II) which is responsible for the above mentioned differences, seems to us very unrealistic, since this residue is situated relatively far away from the active site, and could account for such a difference in affinity only for inhibitors with an extremely long and flexible molecule.
In conclusion, in this paper we present novel types of very potent CA inhibitors from the class of the metal complexes of heterocyclic sulfonamides, together with a new hypothesis to explain the different affinity of such inhibitors for the physiologically relevant isozymes CA I, II and IV.
